Chemotherapy with or without pemetrexed as second-line regimens for advanced non-small-cell lung cancer patients who have progressed after first-line EGFR TKIs: a systematic review and meta-analysis.
Onco Targets Ther
; 11: 3697-3703, 2018.
Article
em En
| MEDLINE
| ID: mdl-29983578
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Tipo de estudo:
Clinical_trials
/
Observational_studies
/
Systematic_reviews
Idioma:
En
Ano de publicação:
2018
Tipo de documento:
Article